Experienced in Pediatric Myocarditis

Dr. Judith L. Kirstein

Family Medicine
8846 S Redwood Rd, Ste E121, 
West Jordan, UT 
Experienced in Pediatric Myocarditis
8846 S Redwood Rd, Ste E121, 
West Jordan, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Judith Kirstein is a primary care provider, practicing in Family Medicine in West Jordan, Utah. Dr. Kirstein is rated as an Experienced provider by MediFind in the treatment of Pediatric Myocarditis. Her top areas of expertise are Tetanus, Yellow Fever, Pediatric Myocarditis, and Dengue Fever.

Her clinical research consists of co-authoring 9 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pediatric Myocarditis.

Specialties
Family Medicine
Licenses
Family Medicine in UT
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

8846 S Redwood Rd, Ste E121, West Jordan, UT 84088

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Phase I/II, Randomised, Controlled Study to Assess the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine When Administered to Healthy Adults (Phase I) and to Healthy Adolescents and Adults (Phase II)
A Phase I/II, Randomised, Controlled Study to Assess the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine When Administered to Healthy Adults (Phase I) and to Healthy Adolescents and Adults (Phase II)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Combination product, Biological
Study Phase: Phase 1/Phase 2
A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents
A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents
Enrollment Status: Completed
Publish Date: August 30, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
View 7 Less Clinical Trials

9 Total Publications

BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.
Journal: Journal of cachexia, sarcopenia and muscle
Published: May 28, 2024
Similar Doctors
Experienced in Pediatric Myocarditis
Dr. John M. Hemmersmeier
Family Medicine
Experienced in Pediatric Myocarditis
Dr. John M. Hemmersmeier
Family Medicine

Ogden Clinic - South Ogden Center For Family Medicine

5740 Crestwood Drive, 
Ogden, UT 
 (39.2 miles away)
801-479-7771
Experience:
25+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Hemmersmeier is a primary care provider, practicing in Family Medicine in Ogden, Utah. Dr. Hemmersmeier has been practicing medicine for over 25 years and is rated as a Distinguished provider by MediFind in the treatment of Pediatric Myocarditis. His top areas of expertise are Type 2 Diabetes (T2D), Osteomyelitis in Children, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Endoscopy. Dr. Hemmersmeier is currently accepting new patients.

Experienced in Pediatric Myocarditis
Dr. Gregory A. Baird
Family Medicine
Experienced in Pediatric Myocarditis
Dr. Gregory A. Baird
Family Medicine

ToGo Healthcare

Bluffdale, UT 
 (6.7 miles away)
801-919-3008
Experience:
13+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregory Baird is a primary care provider, practicing in Family Medicine in Bluffdale, Utah. Dr. Baird has been practicing medicine for over 13 years and is rated as an Advanced provider by MediFind in the treatment of Pediatric Myocarditis. His top areas of expertise are Dementia, Protein Deficiency, Malnutrition, and Peptic Ulcer. Dr. Baird is currently accepting new patients.

Experienced in Pediatric Myocarditis
Dr. Mark D. Johnson
Family Medicine
Experienced in Pediatric Myocarditis
Dr. Mark D. Johnson
Family Medicine
6321 S Redwood Rd, Suite 201, 
Salt Lake City, UT 
 (3.2 miles away)
801-265-2212
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Johnson is a primary care provider, practicing in Family Medicine in Salt Lake City, Utah. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Pediatric Myocarditis. His top areas of expertise are Familial Hypertriglyceridemia, Type 2 Diabetes (T2D), Osteomyelitis in Children, and Glucocorticoid-Remediable Aldosteronism. Dr. Johnson is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kirstein's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile